DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment ...

After three years of VP250, 83.5% of participants reached an eliciting dose (ED) of ≥1000 mg, an increase from 64.2% at month ...

Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of neffy (epinephrine nasal ...

Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Epinephrine Autoinjector Market offers comprehensive insights into the market landscape, customer ...

lily_rocha – stock.adobe.com) The study published in the International Archives of Allergy and Immunology, which tracked over 1,100 emergency cases across Canada over a decade, challenges previous ...

(previously referred to as ARS-1), an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who ...

Recent study evaluated the impact of administering an initial intramuscular (IM) adrenaline dose on survival outcomes in patients experiencing out-of-hospital cardiac arrest (OHCA). The objective was ...

Epinephrine is also available as a nasal spray, which is subject to the same guidelines under the updated draft Kelso policy. It is used to treat anaphylaxis, a severe allergic reaction that ...

There’s two main reasons both the Ghost and Adrenaline draw new and veteran runners to choose them as their workhorse shoe: a soft, comfy interior, and equally soft but firm and supportive ...

The PharmFilm platform serves as the foundation for Aquestive's most promising product candidate, Anaphylm, an epinephrine sublingual film designed for treating Type 1 allergic reactions, including ...